CoChat

Interleukin-6 regulates pancreatic α-cell mass expansion

Open access
Ellingsgaard, Helga, Ehses, Jan A., Hammar, Eva B., Van Lommel, Leentje, Quintens, Roel, Martens, Geert, Kerr-Conte, Julie, Pattou, Francois, Berney, Thierry, Pipeleers, Daniel, Halban, Philippe A., Schuit, Frans C., Donath, Marc Y. · 2008 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Interleukin-6 (IL-6) is systemically elevated in obesity and is a predictive factor to develop type 2 diabetes. Pancreatic islet pathology in type 2 diabetes is characterized by reduced β-cell function and mass, an increased proportion of α-cells relative to β-cells, and α-cell dysfunction. Here we show that the α cell is a primary target of IL-6 actions. Beginning with investigating the tissue-specific expression pattern of the IL-6 receptor (IL-6R) in both mice and rats, we find the highest expression of the IL-6R in the endocrine pancreas, with highest expression on the α-cell. The islet IL-6R is functional, and IL-6 acutely regulates both pro-glucagon mRNA and glucagon secretion in mouse and human islets, with no acute effect on insulin secretion. Furthermore, IL-6 stimulates α-cell proliferation, prevents apoptosis due to metabolic stress, and regulates α-cell mass in vivo . Using IL-6 KO mice fed a high-fat diet, we find that IL-6 is necessary for high-fat diet-induced increased α-cell mass, an effect that occurs early in response to diet change. Further, after high-fat diet feeding, IL-6 KO mice without expansion of α-cell mass display decreased fasting glucagon levels. However, despite these α-cell effects, high-fat feeding of IL-6 KO mice results in increased fed glycemia due to impaired insulin secretion, with unchanged insulin sensitivity and similar body weights. Thus, we conclude that IL-6 is necessary for the expansion of pancreatic α-cell mass in response to high-fat diet feeding, and we suggest that this expansion may be needed for functional β-cell compensation to increased metabolic demand.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0801059105

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 3

  1. 10.1210/endo.136.9.7649117 · doi:10.1210/endo.136.9.7649117 · Paper page
  2. 10.1002/1096-9896(2000)9999:9999<::aid-path633>3.0.co;2-x · doi:10.1002/1096-9896(2000)9999:9999<::aid-path633>3.0.co;2-x
  3. MS Winzell, J Ahren, E Renstrom, B Ahren, Beta cell specific overexpression of glucagon receptors results in improved insulin secretion in response to glucose but impaired response to glucagon. Diabetologia 50, S28 (2007).

Cited by

See all 281

Metadata

Authors
Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P. A., Schuit, F. C., & Donath, M. Y.
Affiliations
  • University Hospital Zurich (CH)
  • University of Geneva (CH)
  • Gene Expression Unit, Department of Molecular Cell Biology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium;
  • KU Leuven (BE)
  • Diabetes Research Center, Brussels Free University, Laarbeeklaan 103, B-1090 Brussels, Belgium; and
  • Inserm (FR)
  • **Cell Therapy of Diabetes, ERIT-M 0106, Institut National de la Santé et de la Recherche Médicale, Faculty of Medicine, 1 Place de Verdun, 59045 Lille, France
Venue
Proceedings of the National Academy of Sciences
Published
2008-09-02
Volume
105
Issue
35
Pages
13163-13168
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2032658955
Cited by
269
References
40
Citations by year
2026: 1 · 2025: 9 · 2024: 21 · 2023: 22 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 14 · 2015: 22 · 2014: 18 · 2013: 23 · 2012: 17
FWCI
13.03
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
interleukin-6, alpha cells, IL-6 receptor, glucagon secretion, alpha-cell proliferation, high-fat diet, type 2 diabetes, beta-cell compensation, insulin secretion, obesity, islets
MeSH terms
Animals, Dietary Fats, Feeding Behavior, Gene Expression Regulation, Glucagon, Glucose Tolerance Test, Humans, Male, Mice, Inbred C57BL, Phosphorylation, Protein Precursors, RNA, Messenger, Interleukin-6, Rats, Wistar, Apoptosis, Mice, Knockout, Receptors, Interleukin-6, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, STAT3 Transcription Factor, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-6 regulates pancreatic α-cell mass expansion. https://app.cochat.ai/papers/10.1073/pnas.0801059105
The paper
Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P. A., Schuit, F. C., & Donath, M. Y. (2008). Interleukin-6 regulates pancreatic α-cell mass expansion. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0801059105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.